Subject: Diseases of the blood and blood-forming organs | Case Report | RC633-647.5 | Article Subject
Necrotizing fasciitis is a fulminant soft tissue infection characterized by rapid progression and high mortality. Rituximab is a generally well-tolerated immunosuppresive medication used for B-cell malignancies and some rheumatological disorders. We report a case of a 6... View more
Emery, P., Deodhar, A., Rigby, W. F.. Efficacy and safety of different doses and retreatment of rituximab: A randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE)) (Annals of the Rheumatic Diseases (2010) 69, (1629-1635)).
Annals of the Rheumatic Diseases
. 2011; 70 (8): p. 1519
Lazzeri, D., Agostini, T., Figus, M., Nardi, M., Pantaloni, M., Lazzeri, S.. More on periorbital infections following therapy with biological agents.
Cutaneous and Ocular Toxicology
. 2011; 30 (4): 338-339